Pearn J H, Wilson J
Arch Dis Child. 1973 Oct;48(10):768-74. doi: 10.1136/adc.48.10.768.
Recent studies have shown that the acute fatal form of infantile spinal muscular atrophy (acute Werdnig-Hoffmann disease or spinal muscular atrophy Type I) is a distinct genetic and clinical entity. This has prompted clinical re-examination of the disease known as `arrested Werdnig-Hoffmann disease' which hitherto was thought to be a spectrum variant of the acute fatal form. A total of 18 such patients with the chronic generalized form of spinal muscular atrophy has been known to The Hospital for Sick Children over the past 10 years. Patients with this characteristic clinical syndrome comprise approximately one-fifth of children with chronic spinal muscular atrophy. Clinically, no patient was even able to crawl normally or progress further with motor milestones. Median age of clinical onset is 6 months of age, and life expectancy ranges from 2 years to the third decade. Inevitable spinal and joint deformities occur by the second decade of life. Management should be based on vigorous antibiotic therapy, orthopaedic and neurological surveillance, and a carefully planned educational programme aimed at realistic employment in late adolescence.
最近的研究表明,婴儿脊髓性肌萎缩症的急性致死型(急性韦尼克-霍夫曼病或Ⅰ型脊髓性肌萎缩症)是一种独特的遗传和临床实体。这促使对一种被称为“静止性韦尼克-霍夫曼病”的疾病进行临床重新审视,该疾病此前被认为是急性致死型的一种谱系变体。在过去10年里,病童医院共收治了18例这种慢性全身性脊髓性肌萎缩症患者。患有这种典型临床综合征的患者约占慢性脊髓性肌萎缩症患儿的五分之一。临床上,没有患者能够正常爬行或在运动发育里程碑上取得进一步进展。临床发病的中位年龄为6个月,预期寿命从2岁到第三个十年不等。到第二个十年时,不可避免地会出现脊柱和关节畸形。治疗应基于积极的抗生素治疗、骨科和神经学监测,以及一项精心规划的教育计划,目标是在青春期后期实现切实可行的就业。